Crescent Energy Among The 'Very Best' E&P Companies, Says Analyst: SilverBow Deal Offers 'Clear Synergies'
Crescent Energy Among The 'Very Best' E&P Companies, Says Analyst: SilverBow Deal Offers 'Clear Synergies'
Crescent Energy Co (NYSE:CRGY) inked an agreement to acquire SilverBow Resources Inc (NYSE:SBOW) for $2.1 billion.
Crescent Energy Co（纽约证券交易所代码：CRGY）签署了一项协议，以21亿美元的价格收购SilverBow Resources Inc（纽约证券交易所代码：SBOW）。
While the company has been growing mainly through acquisitions, the purchase of SilverBow Resources "is the most impactful to date," according to KeyBanc Capital Markets.
根据KeyBanc资本市场的数据，尽管该公司主要通过收购实现增长，但对SilverBow Resources的收购 “是迄今为止影响最大的收购”。
The Crescent Energy Analyst: Tim Rezvan initiated coverage of Crescent Energy with an Overweight rating and price target of $16.
新月能源分析师：蒂姆·雷兹万启动了对新月能源的报道，增持评级，目标股价为16美元。
The Crescent Energy Thesis: The acquisition of SilverBow Resources will add to Crescent Energy's scale and production in the Eagle Ford, Rezvan said in the initiation note.
新月能源论点：雷兹万在启动说明中表示，收购SilverBow Resources将扩大Crescent Energy在鹰福特的规模和产量。
Check out other analyst stock ratings.
查看其他分析师股票评级。
The purchase offers "clear synergies that can be attained, both financially (lower cost of capital, lower G&A/boe) and operationally (more simul-frac opportunities, best practices in the field and hydrocarbon optionality in the Eagle Ford)," the analyst wrote.
该分析师写道，此次收购提供了 “明显的协同效应，无论是在财务上（更低的资本成本，更低的G&A/BoE），还是在运营上（更多的模拟压裂机会、该领域的最佳实践以及Eagle Ford的碳氢化合物可选性）。”
The 2025 estimates for Crescent Energy's free cash flow yield ranks "among the very best of any E&P company under coverage," Rezvan stated.
雷兹万说，对2025年Crescent Energy自由现金流收益率的估计 “在所有所涵盖的勘探和生产公司中名列前茅”。
"The increased size of the Company, in addition to more high-quality inventory, warrants multiple expansion," he added.
他补充说：“公司规模的扩大，加上更多的高质量库存，保证了多次扩张。”
CRGY Price Action: Shares of Crescent Energy had risen by 0.69% to $11.71 at the time of publication on Thursday.
CRGY价格走势：截至周四发布时，Crescent Energy的股价上涨了0.69％，至11.71美元。
Now Read:
现在阅读：
- Stock Of The Day: It's No Coincidence CVS Health Stock Found Support Where It Did
- 每日股票：CVS Health 股票在原地获得支撑绝非偶然